tisagenlecleucel,axicabtagene ciloleucel
daiichi sankyo,gilead,novartis
['1427', 'axi-cel', 'elevate,(-elevate uc),(-elevateuc),(-elevate-uc),(-elevate rr),(-elevaterr),(-elevate-rr),(-elevate tn),(-elevatetn),(-elevate-tn)', 'tisa-cel', 'lymphoma', 'lymsm']
going on simulataneously in the aggressive lymphoma #ash22 session: hyperferritinemia, receipt of tisa-cel car-t product, and elevated ldh were risk factors for inferior pfs and os in patients with icans / neurotoxicity during car-t therapy. #lymsm #tcellrx 
#lymsm & #mmsm hematologist & patient-reported outcomes researcher @CUHematology. Founder of https://t.co/kN6qeGXfg5, @inTrainingDoc & @inHouseMag. ??????